1. Home
  2. EXAS vs GPC Comparison

EXAS vs GPC Comparison

Compare EXAS & GPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

N/A

Current Price

$103.31

Market Cap

19.7B

Sector

Health Care

ML Signal

N/A

Logo Genuine Parts Company

GPC

Genuine Parts Company

N/A

Current Price

$108.15

Market Cap

16.3B

ML Signal

N/A

Company Overview

Basic Information
Metric
EXAS
GPC
Founded
1995
1928
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Automotive Aftermarket
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
19.7B
16.3B
IPO Year
2000
1994

Fundamental Metrics

Financial Performance
Metric
EXAS
GPC
Price
$103.31
$108.15
Analyst Decision
Hold
Buy
Analyst Count
17
6
Target Price
$86.62
$145.67
AVG Volume (30 Days)
1.8M
1.6M
Earning Date
05-07-2026
05-22-2026
Dividend Yield
N/A
3.89%
EPS Growth
80.32
N/A
EPS
N/A
0.47
Revenue
$4,144,000.00
$24,300,141,000.00
Revenue This Year
$15.37
$5.46
Revenue Next Year
$12.41
$3.80
P/E Ratio
N/A
$232.47
Revenue Growth
N/A
3.46
52 Week Low
$38.88
$104.01
52 Week High
$104.02
$151.57

Technical Indicators

Market Signals
Indicator
EXAS
GPC
Relative Strength Index (RSI) 54.45 26.51
Support Level $102.95 N/A
Resistance Level $103.77 $129.07
Average True Range (ATR) 0.31 2.80
MACD -0.09 -0.89
Stochastic Oscillator 33.18 6.57

Price Performance

Historical Comparison
EXAS
GPC

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

About GPC Genuine Parts Company

Genuine Parts sells aftermarket automotive parts (60% of sales) and industrial products (40% of sales) in the United States and internationally. The automotive segment primarily acts as a distributor to its network of 9,800 global retail locations, of which about two-thirds are independently owned and operated. We estimate Genuine serves around 6,000 retail locations in the US operating under the Napa Auto Parts brand, with about 80% of end-market sales derived from professional customers. Its industrial segment, primarily operating under the Motion name in the United States, is a leading distributor of bearings, power transmission, and other industrial products to more than 200,000 maintenance, repair, and original equipment manufacturer customers.

Share on Social Networks: